查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1376389

心肺自動輸血系統市場：按產品、應用和最終用戶 - 全球預測 2023-2030

Cardiopulmonary Autotransfusion Systems Market by Product (Off-Pump Transfusion Device, On-Pump Transfusion Device), Application (Cardiac Surgery, Organ Transplant, Orthopedic Surgery), End User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

心肺自動輸血系統市場預計將從 2022 年的 5.5236 億美元增至 2030 年的 6.8931 億美元，預測期內年複合成長率為 2.80%。

自動化心肺機輸血系統的全球市場

主要市場統計
市場金額：基準年 [2022] 5.5236億美元
預計市場價值 [2023] 5.6662 億美元
預計市場規模[2030]68931萬美元 68931萬美元
年複合成長率（%） 2.80%
心肺自動輸血系統市場-IMG1

FPNV定位矩陣

FPNV 定位矩陣是評估心肺自動輸血系統市場的重要工具。透過分析與業務策略和產品滿意度相關的關鍵指標來全面評估供應商。這使得使用者能夠根據自己的具體資訊做出明智的決策。進階分析將供應商分為四個像限，每個象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。這個富有洞察力的框架使決策者能夠充滿信心地駕馭市場。

市場佔有率分析

市場佔有率分析為供應商的市場形勢提供了寶貴的見解。評估對整體收益、客戶群和其他關鍵指標的影響可以全面了解公司的業績及其面臨的競爭環境。該分析還揭示了研究期間的競爭水平，例如市場佔有率成長、碎片化、主導地位和行業整合。

該報告對以下幾個方面提供了寶貴的見解：

1.市場滲透：提供有關市場動態和主要企業產品的全面資訊。

2. 市場開拓：詳細分析新興和成熟細分市場的滲透情況，以突顯利潤豐厚的商機。

3. 市場多元化：有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：對未來技術、研發活動和突破性產品開發的智慧洞察。

本報告解決了以下關鍵問題：

1.心肺機自動輸血系統市場規模及預測如何？

2.心肺自動輸血系統市場中哪些產品、細分市場、應用和領域具有最高的投資潛力？

3.心肺機自動輸血系統市場的競爭策略窗口有哪些？

4.心肺人工自動輸血系統市場的最新技術趨勢和法律規範是什麼？

5.心肺人工自動輸血系統市場主要供應商的市場佔有率是多少？

6.進入心肺機自動化輸血系統市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 高齡化和心血管手術數量增加
      • 醫療保健成本上升和手術進步
      • 血液儲存需求不斷增加
    • 抑制因素
      • 系統成本高、操作複雜
    • 機會
      • 自動化心肺機輸血系統技術進展
      • 血液處理技術與先進過濾系統的創新
    • 任務
      • 對感染風險和污染問題的擔憂
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 心肺自動輸血系統市場：依產品

  • 非體外循環輸血裝置
  • 體外循環輸血裝置

第7章 心肺自動輸血系統市場：依應用分類

  • 心血管手術
  • 器官移植
  • 整形外科
  • 創傷治療

第8章 心肺自動輸血系統市場：依最終使用者分類

  • 門診手術中心
  • 心臟研究中心
  • 醫院

第9章 美洲心肺自動輸血系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太心肺自動輸血系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲心肺自動輸血系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情境分析：主要企業

第13章競爭產品組合

  • 主要企業簡介
    • Advancis Surgical
    • Becton, Dickinson and Company
    • Beijing ZKSK Technology Co., Ltd.
    • Braile Biomedica
    • Brightwake Ltd.
    • Fresenius Kabi
    • Getinge AB
    • Global Blood Resources, LLC
    • LivaNova International
    • Medtronic PLC
    • ProCell Surgical
    • SARSTEDT
    • Stryker Corporation
    • Teleflex Incorporated
    • Terumo Interventional Systems
    • Zimmer Biomet Holdings, Inc.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-69324464D33E

The Cardiopulmonary Autotransfusion Systems Market is projected to reach USD 689.31 million by 2030 from USD 552.36 million in 2022, at a CAGR of 2.80% during the forecast period.

Global Cardiopulmonary Autotransfusion Systems Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 552.36 million
Estimated Year Value [2023] USD 566.62 million
Forecast Year Value [2030] USD 689.31 million
CAGR (%) 2.80%
Cardiopulmonary Autotransfusion Systems Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Cardiopulmonary Autotransfusion Systems Market.

Based on Product, market is studied across Off-Pump Transfusion Device and On-Pump Transfusion Device. The Off-Pump Transfusion Device is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cardiac Surgery, Organ Transplant, Orthopedic Surgery, and Trauma Procedures. The Orthopedic Surgery is projected to witness significant market share during forecast period.

Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Research Centers, and Hospitals. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Cardiopulmonary Autotransfusion Systems Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Cardiopulmonary Autotransfusion Systems Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Cardiopulmonary Autotransfusion Systems Market, highlighting leading vendors and their innovative profiles. These include Advancis Surgical, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Brightwake Ltd., Fresenius Kabi, Getinge AB, Global Blood Resources, LLC, LivaNova International, Medtronic PLC, ProCell Surgical, SARSTEDT, Stryker Corporation, Teleflex Incorporated, Terumo Interventional Systems, and Zimmer Biomet Holdings, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Cardiopulmonary Autotransfusion Systems Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Cardiopulmonary Autotransfusion Systems Market?

3. What is the competitive strategic window for identifying opportunities in the Cardiopulmonary Autotransfusion Systems Market?

4. What are the latest technology trends and regulatory frameworks in the Cardiopulmonary Autotransfusion Systems Market?

5. What is the market share of the leading vendors in the Cardiopulmonary Autotransfusion Systems Market?

6. Which modes and strategic moves are suitable for entering the Cardiopulmonary Autotransfusion Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cardiopulmonary Autotransfusion Systems Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging population and increase in number of cardiac surgeries
      • 5.1.1.2. Rising healthcare expenditure and advancements in surgical procedures
      • 5.1.1.3. Increasing demand for blood conservation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the system and operational complexity
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the cardiopulmonary autotransfusion systems
      • 5.1.3.2. Innovations in the blood processing techniques and advanced filtration systems
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with infection risks and contamination issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Cardiopulmonary Autotransfusion Systems Market, by Product

  • 6.1. Introduction
  • 6.2. Off-Pump Transfusion Device
  • 6.3. On-Pump Transfusion Device

7. Cardiopulmonary Autotransfusion Systems Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiac Surgery
  • 7.3. Organ Transplant
  • 7.4. Orthopedic Surgery
  • 7.5. Trauma Procedures

8. Cardiopulmonary Autotransfusion Systems Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Cardiac Research Centers
  • 8.4. Hospitals

9. Americas Cardiopulmonary Autotransfusion Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiopulmonary Autotransfusion Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Advancis Surgical
    • 13.1.2. Becton, Dickinson and Company
    • 13.1.3. Beijing ZKSK Technology Co., Ltd.
    • 13.1.4. Braile Biomedica
    • 13.1.5. Brightwake Ltd.
    • 13.1.6. Fresenius Kabi
    • 13.1.7. Getinge AB
    • 13.1.8. Global Blood Resources, LLC
    • 13.1.9. LivaNova International
    • 13.1.10. Medtronic PLC
    • 13.1.11. ProCell Surgical
    • 13.1.12. SARSTEDT
    • 13.1.13. Stryker Corporation
    • 13.1.14. Teleflex Incorporated
    • 13.1.15. Terumo Interventional Systems
    • 13.1.16. Zimmer Biomet Holdings, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET DYNAMICS
  • FIGURE 7. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 10. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 12. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY OFF-PUMP TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ON-PUMP TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ORGAN TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 145. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 146. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET LICENSE & PRICING